Molecular portraits of human breast tumours

Nature

Volumn 406, Issue 6797, 2000, Pages 747-752

  Perou, Charles M ^a   Sørile, Therese ^b   Eisen, Michael B ^a   Van De Rijn, Matt ^a   Jeffrey, Stefanie S ^a   Ress, Christian A ^a   Pollack, Jonathan R ^a   Ross, Douglas T ^a   Johnsen, Hilde ^b   Akslen, Lars A ^c   Fluge, Øysteln ^d   Pergammenschlkov, Alexander ^a   Williams, Cheryl ^a   Zhu, Shirley X ^a   Lønning, Per E ^e   Børresen Dale, Anne Lise ^b   Brown, Patrick O ^a   Botstein, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, ERBB-2; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0034680102     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35021093     Document Type: Article

References (23)

1. Tavassoli, F. A. & Schnitt, S. J. Pathology of the Breast (Elsevier, New York, 1992).
2. Eisen, M. B. & Brown, P. O. DNA arrays for analysis of gene expression. Methods Enzymol. 303, 179-205 (1999).
3. Ross, D. T. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nature Genet. 24, 227-235 (2000).
4. Aas, T. et al. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med 2, 811-814 (1996).
5. Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998).
6. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-9217 (1999).
7. Yang, G. P., Ross, D. T., Kuang, W. W., Brown, P. O. & Weigel, R. J. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res. 27, 1517-1523 (1999).
8. Hoch, R. V., Thompson, D. A., Baker, R. J. & Weigel, R. J. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer 84, 122-128 (1999).
9. Pauletti, G., Godolphin, W., Press, M. F. & Slamon, D. J. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13, 63-72 (1996).
10. Pollack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23, 41-46 (1999).
11. Ronnov-Jessen, L., Petersen, O. W. & Bissell, M. J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69-125 (1996).
12. Taylor-Papadimitriou, J. et al. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell Sci. 94, 403-413 (1989).
13. Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
14. Dairkee, S. H., Mayall, B. H., Smith, H. S. & Hackett, A. J. Monoclonal marker that predicts early recurrence of breast cancer. Lancet 1, 514 (1987).
15. Dairkee, S. H., Puett, L. & Hackett, A. J. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue. J. Natl Cancer Inst. 80, 691-695 (1988).
16. Malzahn, K., Mitze, M., Thoenes, M. & Moll, R. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arth. 433, 119-129 (1998).
17. Guelstein, V. I. et al. Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int. J. Cancer 42, 147-153 (1988).
18. Gurterson, B. A. et al. Distribution of myoepithelial cell and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res. 42, 4763-4770 (1982).
19. Nagle, R. B. et al. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J. Histochem. Cytochem. 34, 869-881 (1986).
20. Berns, E. M. et al. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumors: correlation with steroid receptors. Eur. J. Cancer 28, 697-700 (1992).
21. Heintz, N. H., Leslie, K. O., Rogers, L. A. & Howard, P. L. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. Arch. Pathol. Lab. Med. 114, 160-163 (1990).
22. DeRisi, J. L., Iyer, V. R. & Brown, P. O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680-686 (1997).
23. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).